{
    "id": "51078630",
    "text": "Brazikumab (INN; development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease.Statement On A Nonproprietary Name Adopted By The USAN Council - Brazikumab, American Medical Association. This drug was developed by MedImmune. == References == Category:Monoclonal antibodies Category:AstraZeneca brands ",
    "title": "Brazikumab"
}